Snow Brand Report issue

Contributed to NME For profit
Founded: Tokyo Japan (1950)
Status: Left NME R&D (2018)

Organization Overview

First Clinical Trial
2013
NCT02592122
First Marketed Drug
2000
cevimeline hydrochloride (evoxac)
First NDA Approval
2000
cevimeline hydrochloride (evoxac)
Last Known Activity
2013

Timeline

NOW
  • Now

Alternative names

snow